FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

CF O'Neill

Research Profile

Chemicals & Drugs

Anatomy

Tumor Cells, Cultured

Disorders

Physiology

Procedures

Living Beings

Mouse

Co-author Network

Publications

TOP 3
SY Sharp; CF O'Neill; P Rogers; Frances E Boxall; Lloyd R Kelland
Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin.
R M Orr; CF O'Neill
Patent review: therapeutic applications for antisense oligonucleotides 1999-2000.
CF O'Neill; B Koberle; J R Masters; Lloyd R Kelland
Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of CF O'Neill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: SY Sharp; CF O'Neill; P Rogers; Frances E Boxall; Lloyd R Kelland
Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin.
European journal of cancer (Oxford, England : 1990) 2002;38(17):2309-15.
2000: R M Orr; CF O'Neill
Patent review: therapeutic applications for antisense oligonucleotides 1999-2000.
Current opinion in molecular therapeutics 2000;2(3):325-31.
1999: CF O'Neill; B Koberle; J R Masters; Lloyd R Kelland
Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
British journal of cancer 1999;81(8):1294-303.
1999: CF O'Neill; L Hunakova; Lloyd R Kelland
Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
Chemico-biological interactions 1999;123(1):11-29.
1999: Lloyd R Kelland; SY Sharp; CF O'Neill; Florence I Raynaud; Philip Beale; Ian R Judson
Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
Journal of inorganic biochemistry 1999;77(1-2):111-5.
1996: M G Ormerod; R M Orr; CF O'Neill; T Chwalinski; J C Titley; Lloyd R Kelland; K R Harrap
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.
British journal of cancer 1996;74(12):1935-43.
1996: CF O'Neill; M G Ormerod; D Robertson; J C Titley; Y Cumber-Walsweer; Lloyd R Kelland
Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex.
British journal of cancer 1996;74(7):1037-45.
1994: R M Orr; CF O'Neill; M C Nicolson; C F Barnard; BA Murrer; C M Giandomenico; J F Vollano; K R Harrap
Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
British journal of cancer 1994;70(3):415-20.
1994: M G Ormerod; CF O'Neill; D Robertson; K R Harrap
Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA.
Experimental cell research 1994;211(2):231-7.
1992: Lloyd R Kelland; P Mistry; G Abel; S Y Loh; CF O'Neill; BA Murrer; K R Harrap
Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
Cancer research 1992;52(14):3857-64.
1992: M C Nicolson; R M Orr; CF O'Neill; K R Harrap
The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
Neoplasma 1992;39(3):189-95.